Compare CHCO & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CHCO | HTFL |
|---|---|---|
| Founded | 1957 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 1995 | N/A |
| Metric | CHCO | HTFL |
|---|---|---|
| Price | $145.73 | $28.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $132.50 | $38.20 |
| AVG Volume (30 Days) | 126.6K | ★ 1.0M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ 13.18 | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.16 | $27.66 |
| Revenue Next Year | $3.12 | $23.55 |
| P/E Ratio | $31.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $113.21 | $20.13 |
| 52 Week High | $147.58 | $41.22 |
| Indicator | CHCO | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 70.24 | 51.38 |
| Support Level | $120.29 | $25.56 |
| Resistance Level | N/A | $32.69 |
| Average True Range (ATR) | 3.34 | 1.28 |
| MACD | 0.26 | 0.45 |
| Stochastic Oscillator | 84.10 | 90.83 |
City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.